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Proper inhaler technique is crucial for effective management of asthma and COPD. This multi-
centre, cross-sectional, observational study investigates the prevalence of inhaler mishandling
in a large population of experienced patients referring to chest clinics; to analyze the variables
associated with misuse and the relationship between inhaler handling and health-care
resources use and disease control.
We enrolled 1664 adult subjects (mean age 62 years) affectedmostly by COPD (52%) and asthma
(42%). Respectively, 843 and 1113 patients were using MDIs and DPIs at home; of the latter, the
users of Aerolizer, Diskus, HandiHaler and Turbuhaler were 82, 467, 505 and 361.ctive pulmonary disease; MDI, press-and-breathe metered dose inhaler; DPI, dry powder inhaler;
fluoroalkane; ACT, asthma control test; ICS, inhaled corticosteroids; LABA, long-acting beta-2-
gonists; MRC, medical research council; FEV1, forced expiratory volume in 1 s; FVC, forced vital
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Inhaler mishandling remains common in real life and is associated with reduced disease control 931We have a total of 2288 records of inhaler technique. Critical mistakes were widely distrib-
uted among users of all the inhalers, ranging from 12% for MDIs, 35% for Diskus and HandiHaler
and 44% for Turbuhaler. Independently of the inhaler, we found the strongest association
between inhaler misuse and older age (p Z 0.008), lower schooling (p Z 0.001) and lack of
instruction received for inhaler technique by health caregivers (p < 0.001). Inhaler misuse
was associated with increased risk of hospitalization (p Z 0.001), emergency room visits
(p < 0.001), courses of oral steroids (p < 0.001) and antimicrobials (p < 0.001) and poor disease
control evaluated as an ACT score for the asthmatics (p < 0.0001) and the whole
population (p < 0.0001).
We conclude that inhaler mishandling continues to be common in experienced outpatients
referring to chest clinics and associated with increased unscheduled health-care resource use
and poor clinical control. Instruction by health caregivers is the only modifiable factor useful
for reducing inhaler mishandling
ª 2011 Elsevier Ltd. All rights reserved.Introduction
Asthma and Chronic Obstructive Pulmonary Disease (COPD)
guidelines increasingly rely onpharmacologicalmanagement
with inhaled drugs. Press-and-breatheMeteredDose Inhalers
(MDIs) and Dry Powder Inhalers (DPIs) are themost commonly
used delivery devices for administering aerosolised drugs.
Effective use of inhalers requires proper inhalation
technique. Chlorofluorocarbon (CFC)eMDIs were the first
marketed inhalers; their misuse has been observed to be
common shortly after their introduction into clinical prac-
tice1 and associated with poor clinical outcomes, such as
reduced bronchodilation2 and decreased disease control3 in
asthmatics. Manufacturers introduced DPIs as user-friendly
devices. Being breath-actuated, DPIs overcome the diffi-
culties between inhaler actuation and inspiration, one the
most common errors with MDIs. However, a recent review4
has shown that misuse of DPIs is also common in real life.
Whether DPIs mishandling can have clinical consequences
seems to be logical, but it is not demonstrated.4 Although
poor inhaler use is more common in older ages,5 its impact
on outcomes of COPD patients is also unknown, as most real-
life studies on inhalation technique have been carried out
on asthmatics.6
The aim of the present study was to evaluate the inha-
lation technique of a large sample of experienced outpa-
tients referring to chest clinics; to investigate the
prevalence and the factors associated with inhaler misuse;
to assess the relationship between inhalation technique
and some clinical outcomes.
Materials and methods
The GENEBI (AIPO Gruppo Educazionale for NEBulizers and
Inhalers) Project is a cross-sectional, observational study
(ClinicalTrials.gov. identifier: NCT0925-0586) carried out in
24 chest clinics (see centers listed in appendix) throughout
Italy. The centers were located at different latitudes across
Italy and included highly urbanized as well as rural areas,
encompassing a wide range of settings. The study was
performed from July to September 2008.
During the study period all adolescent and adult (age
greater than 14 years) outpatients, attending one of theparticipating centers for a scheduled visit and using an
inhaler regularly at home were considered eligible for
participation. Regular use was defined as utilization of an
inhaler therapy at least once daily for 4 weeks in the 3
months before the enrollment. To meet the busy clinical
practice with limited time, but to minimize selection bias,
investigators were required to enroll their first two
consecutive eligible patients in each working day. The
enrollment always occurred after full explanation of the
study and written informed consent; no one refused to
participate to the survey. The study was conducted in
accordance with the Declaration of Helsinki and Good
Clinical Practice guidelines and approved by the ethics
committee of the participating centers.
Firstly, enrolled patients completed a standardized
questionnaire prepared by the Educational Group members
of the Italian Association of Hospital Pulmonologists (see
translation from the original Italian format in supplemen-
tary data file). The comprehensibility and the reliability of
the items had been previously tested by a group of patients
not enrolled in the present study, previously described in
detail.5 Briefly, each questionnaire consisted of a general
section and specific parts, each related to a specific
inhaler. For practical and statistical reasons, we restricted
our evaluation to MDIs, Aerolizer, Diskus, HandiHaler,
and Turbuhaler, which at present are the most commonly
used inhalers in Italy. Both the general and the specific
sections included a self-compiled and an investigator-filled
part. The self-compiled general section included some
closed-type questions, which, after gathering some
demographic information, investigated clinical data mostly
related to the respiratory disease control in the last
period. Because we had estimated that asthma was one of
the most commonly encountered respiratory diseases, we
have included the Asthma Control Test (ACT),7 extending it
to all enrolled patients. We have also used the modified
Medical Research Council dyspnoea scale,8 a validated tool
which relates to measurements of health status in COPD
patients. Respondents were also asked for unscheduled
medical interventions due to their respiratory disease,
such as visits to an emergency room, and/or hospital
admissions, and/or antimicrobial treatments, and/or
courses of corticosteroid tablets in the last year; being
these data retrospectively collected, the degree of utilized
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investigators. Each specific self-compiled part included
queries about the use of inhaled treatment, the source and
the modalities of education to inhalation technique
received. The physician-filled part evaluated the primary
respiratory diagnosis, the baseline oxyhaemoglobin satu-
ration whilst breathing air at rest, the prescribed inhaler
devices and the drugs used. On enrollment, subjects
underwent spirometry, performed and reported according
to accepted guidelines.9
Then, each patient demonstrated the inhalation tech-
nique with all used devices to the investigator in a quiet
area using a placebo device. Patients were asked to use
their aerosol just as if they would be at home. For each
center, a single trained investigator evaluated the modali-
ties of inhaler use; to standardize their findings, periodic
meetings were held with all the participating observers.
Investigators were blinded to the results of the self-
administered questionnaire when recording the mode of
inhalation. All observations of inhaler use were reported in
accordance to a standardized device checklist described
into the questionnaire. Preliminarily, we had chosen to
focus the analysis of results on critical errors (see their
description in Tables 1 and 2), which are likely to make
therapy with aerosols useless, according to previous
literature.10
Statistical analysis was performed using generalized
linear models (Stata 9, www.stata.com) with Gaussian or
binomial/logit family, as appropriate, including the center
as a cluster (which corresponds to adding it as a random
effect variable) to obtain a robust standard error. Unless
stated otherwise, age, level of education and respiratory
diagnosis (COPD, asthma or other) was included as fixed
effect variables in all models. Data are presented as the
mean  Standard Error unless otherwise specified. A
p-value of <0.05 for a two-tailed test was considered as
significant.Table 1 Step-by-step MDI checklist of proper inhalation techni
Correct step of inhalation technique Checklist of inh
Remove mouthpiece cap Failure to remo
Shake inhaler (suspensions only) Not shaking the
Breathe out before firing No exhalation b
Inhaler upright during firing Not holding the
One inhalation for actuation More actuations
Place mouthpiece between lips and
over tongue
Actuation again
Actuation in the first half of inhalation Actuation in the
Activation after
Fire while breathing in deeply and slowly
and continue until total lung capacity
Stopping inhalat
Forceful inhalat
Inhalation by mouth Inhalation throu
Hold breath for 10 s No or short (less
* Z critical errors.
a All data are presented as the percentage of patients performing th
b Hold the mouthpiece inhaler between open lips (19% of total) or
alternative to place the mouthpiece between closed lips.Results
We enrolled 1664 subjects. The most frequent respiratory
diagnosis was COPD or asthma. Some demographic and
clinical characteristics of studied patients are displayed in
Table 3. As expected, there were significant differences in
smoking status (smokers and ex-smokers vs. never-
smokers), sex, age and spirometric parameters between
groups with asthma and COPD (p < 0.0001).
One thousand-one-hundred-and-thirteen patients were
using DPIs; 843 were using MDIs; of the latter, only 32 (4%)
in association with a valved holding chamber. Respec-
tively, 65% and 83% of Diskus and HandiHaler users
suffered from COPD; subjects using Diskus and Handi-
Haler prevailed among COPD patients (p < 0.0001), while
we did not find any difference for the other studied
inhalers according to the respiratory diagnosis. Six-
hundred-ten (37% of total) patients were using more than
one type of different inhaler; most of these (82%) had
a diagnosis of COPD. Of subjects using both Inhaled
Corticosteroids (ICS) and Long-Acting Beta-2-Agonists
(LABA), 92.5% had prescribed a combination inhaler and
7.5% separated inhalers.
We have recorded 2288 observations of inhalation tech-
nique for 1633 patients (data of 31 patients were lacking or
missed). These findings occurred for a single, two and more
than two devices, respectively in 1098, 506 and 48 cases. In
Tables 1 and 2, we have reported the results of these obser-
vations. Mistakes were widely distributed among users of all
the inhalers. According to our arbitrary criteria, at least one
critical error for MDI, Diskus, HandiHaler and Turbuhaler
was respectively observed for 12%, 34.5%, 35% and 43.5% of
users. A logistic analysis showed that patients using the Dis-
kus (OR 3.4 0.9; pZ 0.0001), the HandiHaler (3.1 0.8;
pZ 0.0001) and the Turbuhaler (6.0 1.8; p < 0.0001) had
an increased risk of committing critical errors compared to
MDIs users; patients using the Diskus (Odds Ratio 0.6  0.1;que and errors recorded in our population.a
alation technique errors Errors, %
of users
ve cap* 0.15
inhaler 37
efore actuation 50
inhaler in the upright position 9
for a single inhalation 19
st teeth, lips, or tongue*,b 0.7
second half of inspiration 18
end of inhalation* 5
ion immediately after firing* 10
ion 52
gh nose whilst and after actuation* 2
than 2e3 s) breath-holding after inhalation 53
e uncorrected step compared to the total number of observations.
even a few centimeters from the open mouth is an acceptable
Table 2 Step-by-step DPI checklist of proper inhalation technique and errors recorded in our population.a
Correct step of inhalation
technique
Checklist of inhalation
technique errors
Errors, % of
HandiHaler/
Aerolizera users
Errors, % of
Diskus users
Errors, % of
Turbuhaler
users
Failure of priming*
Remove or turn cover Failure to open the device 0 0.65 0
Correctly insert capsule Failure to insert the capsule 9 NA NA
Pierce capsule Failure to pierce the capsule 3 NA NA
Failure of loading*
Load dose Incorrect dose loading NA 7.3 14
Hold inhaler upright Keep the inhaler inclined no more than 45
from the vertical axis during loading
NA NA 23
Breathe out the device
mouthpiece
Exhaling into the device mouthpiece
after loading
19 22 14
Inhale deeply and quickly Stopping inhaling prematurely
(not inhaling to TLC)
26 29 22
Inhale by mouth Inhaling by nose* 2 1 0
Place mouthpiece
between lips
Not sealing lips around mouthpiece
during inhalation*
5 5 4
Forceful and deep inhalation Slow and not forceful inhalation* 24 28 22
Breathe out the device
mouthpiece
Exhaling into the device mouthpiece
after inhalation
19 21 11
Breath-hold No breath-holding after inhalation 25 32 28
Control if capsule is broken
and does not contain
residual powder
Do not control whether some powder
drug rests into
the capsule after inhalation
30 N.A. N.A.
All data are presented as the percentage of subjects performing the uncorrected step compared to the total number of observations;
*: Critical errors; N.A.: not applicable to the device.
a Due to the similar instructions of use, the records of HandiHaler and Aerolizer have been grouped in a single column.
Table 3 Some demographic and clinical characteristics of enrolled patients even according to the primary respiratory
diagnosis.
Characteristic COPD (n Z 864) Asthma (n Z 703) Other (n Z 97) Total(n Z 1664)
Male, % of totala 78 43 54 58
Age, mean  SD, yearsa 70  10 51  17 63  16 62  16
Smoking status, %a
Smokers 18 11 16 15
Ex-smokers 71 31 45 51
Never smokers 11 58 39 34
Mean FEV1% pred  SDb 60  20 80  23 77  20 69  24
Mean FEV1/VC  SD, %b 60  14 72  15 76  12 66  16
Diskus usersb 302 141 24 467
HandiHaler usersb 421 58 26 505
MDIs usersb 356 443 44 843
Aerolizer usersb 42 35 5 82
Turbohaler usersb 159 178 24 361
LABA (not ICS) usersb 18 22 7 47
ICS (no LABA) usersb 18 82 8 108
ICS/LABA usersb 759 455 60 1274
SABA usersb 52 49 7 108
Sputum >3 months per year in
the 2 last yearsa
460 202 33 695
a According to the self-compiled part of the questionnaire.
b According to the investigator-filled part of the questionnaire. MDIZ Press-and-breathe Metered Dose Inhaler; PNZ Predicted normal
ICSZ Inhaled Corticosteroids; LABAZ Long-Acting Beta-2-Agonists; SABAZ Short-Acting Beta-2-Agonists; COPDZ Chronic Obstructive
Pulmonary disease; FEV1 Z Forced Expiratory Volume in 1 s; FVC Z Forced Vital Capacity.
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Table 4 Percentage of observations with at least one critical inhaler error for the whole population and the groups with
asthma and COPD according to the items of the ACT.a
Answer COPD % Asthma % Total % OR  SE; P levelb,c
Limited doing desired everyday life for respiratory symptoms
All the time 36 14 32 1.58  0.06; p Z 0.00001
Often 34 30 33
Sometimes 33 33 31
Seldom 25 25 22
Not at all 27 27 21
Frequency of shortness of breath
More than once a day 30 28 30 1.32  0.13; p Z 0.03
Once a day 35 15 29
A few (3e6) times a week 38 24 34
Once or twice a week 30 23 27
Not at all 23 18 21
Use of rescue inhaler
3 or more times a day 33 26 28 1.28  0.13; p Z 0.02
1 or 2 times per day 35 26 33
A few times a week 22 22 22
Once a week or less 27 18 22
Not al all 33 33 28
Rate respiratory disease control
Not at all 34 22 29 1.56  0.15; p < 0.00001
Poorly controlled 30 27 29
Somewhat controlled 37 32 36
Well controlled 30 21 27
Fully controlled 26 16 21
Sleep disturbance for respiratory symptoms, %
Four or more nights a week 39 21 29 1.29  0.12; p Z 0.009
2 or 3 nights a week 30 24 28
Once a week 35 25 32
Once or twice 37 18 29
Not at all 27 21 24
a The ACT test requires that patients recall their experience over the past 30 days and respond to each question using a 5-points Likert
scale where 1 reflects no impairment and 5 maximum impairment.
b Relationship between risk of at least one critical inhaler error and question score.
c Ordered logistic regression adjusted by diagnosis, type of inhaler and patients with more observations (due to use of more than one
type of inhaler) and evaluated by c2 for trend.
934 A.S. Melani et al.pZ 0.002) and the HandiHaler (OR 0.5  0.1; pZ 0.0001)
performed better than the Turbuhaler users.
Regarding the aim of predicting the factors associated
with faulty inhaler technique, we organized a logistic
model where, after adjusting for different device, the risk
of critical errors increased with age (OR 1.12  0.01;
pZ 0.008) and was reduced for higher degree of education
(OR 0.77  0.06; p Z 0.001). Females showed a not
significant trend for a reduced risk of inhaler misuse (OR
0.74  0.12; pZ 0.064). The rate of critical errors was not
associated with the FEV1/VC ratio (OR 1.01  0.01;
p Z 0.23) and the FEV1 (OR 1.00  0.03; p Z 0.93). After
adjustment for age, patients using a single type of inhaler
did not perform critical errors more often than those using
two or more different devices (OR 0.89  0.11; p Z 0.27).
Fifty-one-percent of COPD patients had a modified Medical
Research Council dyspnoea scale score greater than 2;
there was no association between COPD patients with
critical inhaler errors and MRC score (OR 1.10  0.07;p Z 0.75). After adjustment for age, there was no rela-
tionship between risk of at least one critical inhaler error
and the presence of chronic phlegm (OR 1.03  0.11;
p Z 0.45). Asthmatics had a lower risk of critical errors
than COPD patients (OR 0.59  0.12; p Z 0.002), but this
relationship disappeared after adjustment for device, age
and level of instruction (OR 1.1  0.3; p Z 0.62). Subjects
with a resting oxyhaemoglobin saturation value greater than
90% did not differ in risk of inhaler misuse with respect to
more hypoxemic ones (OR 1.01 0.25; pZ 0.96). There was
an association between subjects who did report no or little
perceived benefit from inhaler use and inhaler misuse (OR
1.4 0.2; pZ 0.015). The percentage of observationswith at
least one critical inhaler error for the whole population and
the groups with asthma and COPD according to each item of
the ACT are shown in Table 4; overall, there was an associ-
ation between ACT score and risk of critical error (OR
1.53  0.14; p < 0.0001) as a whole, but even considering
separately the group of asthmatic (OR 1.73  0.26;
Table 5 Percentage of observations of inhaler technique (yesZ at least a critical error; noZ no inhaler error) for the groups
of asthmatic and COPD subjects according to some unscheduled health-care resources use in the last year.
Characteristic COPD Asthma OR  SE; P levela,b
At least a critical inhaler error No Yes No Yes
Hospital admissions, %
Never 62 55 86 76 1.47  0.17; p Z 0.001
1 23 26 9 13
2e3 11 16 3 9
>3 4 3 2 2
Emergency department visits, %
Never 71 64 81 69 1.62  0.20; p Z 0.0006
1 22 24 11 16
2e3 4 10 3 10
>3 3 2 4 5
Antimicrobic courses, %
Never 30 20 41 34 1.50  0.15; p Z 0.00004
1 29 31 30 25
2e3 26 33 18 17
>3 15 15 11 14
Corticosteroid courses, %
Never 37 29 35 27 1.54  0.16; p Z 0.00003
1 22 19 30 35
2e3 30 26 22 19
>3 11 26 13 19
a Relationship between risk of at least a critical inhaler error and self-report of some unscheduled health-care resources use in the
last year.
b Ordered logistic regression adjusted by diagnosis and type of inhaler and evaluated by c2 for trend.
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Table 5 we have described the percentages of observations
with critical inhaler errors (yes Z at least a critical error;
noZ no inhaler errors) for the groups of asthmatic and COPD
subjects according to some unscheduled health-care
resources use in the last year; the finding of critical errors
in inhalation technique was also associated with increased
risk of hospitalization (p Z 0.001), emergency room visits
(p< 0.001), use of antibiotics (p< 0.001) and courses of oral
corticosteroids (p < 0.001); again, there was always
a statistical significance (p < 0.05) even considering sepa-
rately asthmatics and COPD patients. Regarding inhaler
education by health caregivers, our population included one
third of patients reporting no education (including 7% who
had indicated reading the patient information leaflet with no
further explanation), another third only with verbal
instruction and the latter third (34% of total) of patients
having received practical demonstration using a placebo
inhaler. Given that our participants were enrolled in chest
clinics, a respiratory specialist was by far the most common
source of instruction for inhalation technique (58% of total);
other sources of instructionwere general practitioners (18%),
nurse (15%) and pharmacists (3%). Patients who had received
instruction by chest physicians were associated to a lower
risk of critical inhalation errors for all the studied devices (OR
0.71  0.11; p < 0.03). On the contrary, the lack of instruc-
tion by health caregivers increased the risk of critical errors
(OR 2.28  0.05; p < 0.001). A check-up of proper inhalation
technique at follow-up visits was never organized for 276
(35% of total), once for 130 (24%) and more than once for 107(20%) subjects. Thus, patients who had been checked (OR
0.70  0.07; p Z 0.0001) at least once for mastering good
inhaler practice at follow-up visits had a lower risk of critical
inhalation errors for all the studied devices.Discussion
Inhalation is the preferred route for administering drugs to
asthma and COPD patients. Despite advancements in
technology, which have permitted the introduction of more
user-friendly devices, our study has shown that inhaler mis-
handling remains a serious issue for currently available
inhalers. Previously, it had been suggested that it was easier
to learn how to use a DPI as compared to a CFC-MDI.6,11,12
Unfortunately, in real life, as our study has confirmed,
many patients did not receive any inhaler education. No
education by health caregivers on inhaler technique consis-
tently increased the risk ofmisuse for all the studied devices.
In another survey with a similar study design carried out on
2001e2002, approximately 80% of our patients reported
some education of good inhaler technique by health care-
givers (vs. 67% of the present survey) and two third (vs. 34% of
the present survey) received a practical demonstration of
use.5 We think that the increasing current busy clinical
practice and the introduction of newer devices marketed as
user-friendlymay possible favourite reduced rates of inhaler
education in current real life.
We found that the rate of critical errors for DPIs was not
lower than that of MDIs. This result has to be evaluated
936 A.S. Melani et al.cautiously, as our survey was not designed to compare
different devices and our choice of critical errors was not
balanced between inhalers. Likewise, it is difficult to orga-
nize a comparison between studies, because there is no
agreement for any device regarding the clinically significant
inhalermishandlings. For example, no breath-holding and no
full exhalation to residual volume have been reported as the
most common errors using DPIs,4 but they do not seem to
reduce lung drug delivery.13,14 No full exhalation has been
described as an error for MDIs, but a comfortable exhalation
just below or over functional respiratory capacity is a clini-
cally acceptable alternative.15 Advancements in device
technology also contribute to modify the concept of inha-
lation error over time: failing to shake the MDI before actu-
ation has no effect on drug delivery in case of solutions,
while inadequate mixing of the canister content has been
reported to reduce lung deposition up to 50% with suspen-
sions.16 Although our choice of critical errors is based on
previous literature,10 it is arbitrary and deserves discussion.
Regarding the MDIs, the failure to remove cap and incorrect
firing was occasionally observed. Inhalation through nose
was reported in 2% of our subjects as well as in the litera-
ture.15 It has been reported15 that 27% of MDI users showed
poor hand-lung coordination; however, this problem involves
several levels and different clinical consequences: we
considered as a critical error firing after inspiration was
completed or during exhalation: 5% of our subjects showed
this critical mistake, a value in accordance to a previous
review15 where 4% of MDI users actuated the canister at end
of inspiration. Firing the canister in the second half of
inhalation may reduce lung deposition using the CFC-
MDIs,17e20 but it is not critical using extra-fine newer MDIs.21
We considered the cold-freon effect as another critical error
that we observed in 10% of our patients, a percentage similar
to the 6% previously reported.15
Effective use of DPI requires that each dose must be
primed and loaded.We have observed similar rates of failure
(8e11%) for this type of critical error with all the studied DPIs
except for Turbuhaler (29%), which has position-sensitive
loading; this difficulty explains the increased level of mis-
handling in this phase using this device in our as well as other
large studies.22,23 DPIs derive the energy for the emptying of
the drug system from the user inspiratory flow: the failure to
achieve a forceful inspiratory flow through a device is the
most common critical mishandling with DPIs in our series,
amounting to 26e29% according to the different inhaler.
Slow inhalation has been often described as an inhaler mis-
handling.5,12,24 Lenney et al.12 indicated slow inhalation as
a reason for reduced (and not critical!) lung drug delivery.
We are aware that our evaluation of slow inhalation through
a certain DPI as critical error is subjective, but we think that
this finding can be real and clinically relevant, because we
have largely discussed this topic in previous meetings and
decided to include as “slow” inhalation only well defined
observations: for instance, for Aerolizer and Handihaler,
when investigators did not hear the capsule vibrate, which
occurred in 24% of our observations. In another observational
study of ours, respectively, of two groups of 44 and 62
patients showing slow inhalation through the Turbuhaler
and the Diskus by direct observation, 34 (77%) and 37 (60%)
demonstrated a Peak Inspiratory Flow (PIF) lower than 30 l/
min using the In-Check Dial; interestingly, 102 of these 106patients achieved a PIF of at least 30 l/min after proper
education.24 Likewise, our results mirrored those reported
using objective methods in populations similar to ours.25,26
Nsour et al.25 observed a slow inhalation flow through the
Turbuhaler (<30 L/min) in 19% of 74 elderly COPD patients
by using the In-Check Dial. Kamin et al.,26 assessing the
inhalation quality by the Inhalation Manager in a 60e99
years-old group of moderate-to-severe asthmatics, found
critical errors in 31.5% of 366 patients using the Diskus and
66% of 414 using the Turbohaler.
In the literature there is not agreement on the situations
which predispose to inhaler misuse. We have observed the
strongest associations between inhaler misuse and age, level
of education and amount and quality of instruction received
for good inhaler technique. In a multicentre study including
1305 experienced outpatients with asthma and COPD carried
out in 2001e2002, we had found these same associations.27
We would like to stress the role of instruction by health
caregivers for reducing inhaler mishandling, as it is the only
modifiable factor (and independently of the used device!)
among those observed. It has been suggested28 that patients
using two ormore different devices are predisposed to inhaler
misuse as compared to thosewith only one typeof inhaler, but
we did not confirm this finding after adjustment for age.
As already observed, our study has some limitations.
Firstly, our findings on inhalation techniquemay be biased by
the choice of criteria to define the mishandling for each
device. Secondly, our findings were based on investigators’
judgments and, although we attempted to co-ordinate these
observations, they have a subjective basis. However, it is
noteworthy that the finding of inhaler mishandling judged on
a clinical basis was associated with poor disease control and
increased health care resources use. Little information was
previously available about the outcomes of inhaler misuse. In
a large study including 4078 subjects using ICS via CFCeMDIs,
an association between inhalermishandling anduncontrolled
asthma was observed.3 On the contrary, the correction of
MDIs misuse by health caregivers education improved quality
of life in 69 asthmatics.29 Another randomized controlled
study with 48 COPD or asthmatic patients using DPIs reported
subjective improvements in breathlessness after inhaler
training, but no objective measure was recorded.30 At last,
a controlled study including 97 asthmatics who at baseline
was respectively 7% and 13%of Turbuhaler andDiskus users
with good inhaler technique obtained an improvement in
quality of life after a training intervention on inhaler tech-
nique, although the details of mishandling were not
described.31 Our findings confirm and enlarge these previous
studies, showing that inhaler mishandling is not only
a wasting, but may have relevant clinical consequences in
terms of unscheduled health-care resource use and disease
control. The relationship between inhalermisuse and disease
control measured by ACT score was significant for both the
asthmatic group alone and the whole population. Although
the ACT is not devised to ascertain COPD control, items
evaluating chronic phlegm, episodes of breathlessness,
increased use of relievers, sleep disturbances and everyday
limitationmay possibly be considered as indices of instability
even for COPD patients. Furthermore, the association
between poor clinical control and frequency of critical errors
with inhalers in an observational study does not automati-
cally mean that a better inhalation technique would
Inhaler mishandling remains common in real life and is associated with reduced disease control 937necessarily improve clinical control. Several other reasons
may contribute to poor disease control, such as patients with
poor inhalation technique could also be non-adherent to drug
prescriptions or lead uncorrected lifestyle.
In conclusion, this study shows that mishandling of
inhaler technique remains common in real life for both MDIs
and DPIs and is associated with poor clinical control and
increased unscheduled health-care resources in asthma and
COPD patients. Further prospective studies are needed to
assess the value of educational interventions in patients
showing poor inhalation technique and whether improve-
ments in inhalation technique might be related to better
disease control and clinical outcomes.Conflict of interest
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